Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Updating assumptions

Karoon Energy
3:27pm
January 16, 2024
We have updated our assumptions for Bauna and Brent/WTI post calendar year end. A hydrate issue at one of Bauna’s smaller wells has seen Brazil crude production marginally trail our estimates based on ANP data. Stripping this well out, we are not seeing signs of accelerating decline at Bauna. We maintain an Add rating on KAR, with an adjusted A$2.95 TP (was A$3.00).

Good news is in the price after 1H24 trading update

Super Retail Group
3:27pm
January 15, 2024
Super Retail Group performed really well across most of its brands in 1H24. Today’s trading update was a positive surprise, particularly around margins. Profit before tax (PBT) of $200-203m was 14-16% above our forecast, which itself was 1% above consensus. Our expectations for second half earnings haven’t changed materially, but we have taken the first half outperformance into account and increased our full year PBT forecast by 8%. Super Retail has been a key pick of ours for a while but, after a strong run, we think it’s now appropriately valued and we downgrade to HOLD accordingly. We continue to think this business is moving in the right direction and has the right portfolio of brands to succeed, but at 15x FY25F PE, we think it’s now in the price. Our target price increases from $17.00 to $17.50, but there isn’t enough implied TSR to keep us on an Add.

Transitioning to high margin software revenue

Austco Healthcare
3:27pm
January 15, 2024
Austco Healthcare (AHC) develops a range of hardware and software products focused on enhancing communication between patients and primary carers within the hospital. Its key products are master call points (nurse call) and real-time location systems (RTLS) along with a growing high margin recurring model for its software packages. AHC generates 80% of revenue through hardware sales and 20% through software sales. Management is transitioning the business to a 50/50 split between hardware and software revenue which should result in higher margins. AHC expects strong organic growth to continue, while augmenting its offering and accelerating its growth strategy through acquiring technologies complementary to its current offering.

December trading activity

Aust Securities Exchange
3:27pm
January 9, 2024
ASX has recently released its monthly trading activity report for December 2023. It was a better trading month overall for ASX, in our view, with higher cash markets activity (+13%), an uptick in capital raisings (vs the softer pcp) and stronger Futures volumes. However, for the half, it was more of a mixed outcome. Our FY24-FY26 EPS forecasts are lowered by ~1% factoring in the recent trading activity. Our price target is lowered to A$60.20 (from A$60.70) largely on changes to our 1H24 assumptions post the recent release. Hold maintained.

Progress to towards clinical trial start

Tissue Repair
3:27pm
January 8, 2024
Tissue Repair (TRP) expects the Phase 3 trial for venous leg ulcers (VLU) to start recruiting in 4Q24 and top-line results to be reported late CY25. The National Institute of Health estimates the cost of treating VLUs at between US$2.5bn and US$3.5bn in the US. Following a review of our research universe, we revise our coverage approach for TRP. While we will continue to monitor and provide updates, we will cease providing a rating, valuation and forecasts. Thus, our forecasts, target price and recommendation should no longer be relied upon for investment decisions.

Capital raise provides some runway

Control Bionics
3:27pm
January 3, 2024
CBL has completed a capital raising that will provide funds for new product commercialisation and approvals together with working capital to drive sales of the current products. Cashflow has been an ongoing issue with CBL and the capital raising provides some runway to deliver on the strategy set by new CEO Jeremy Steele, although it will be tight. After diluting for the capital raising our valuation has reduced to A$0.058 (from A$0.09). We maintain our Hold recommendation and will closely monitor the quarterly cashflow reports for signs of sales growth and cost control.

Strong finish to CY23

GQG Partners
3:27pm
January 2, 2024
We expect GQG to close FY23 (Dec-23) with ~US$118bn in FUM, +13.4% in 2H23. Flows momentum has been solid in recent months, which we expect continued in Dec-23. We estimate ~US$1.2bn net inflows for Dec-23 (US$10.2bn for CY23). GQG commences FY24 with group FUM ~8.7% above average 2H23 levels and ~16% above average FY23 FUM. We mark-to-market earnings on recent FUM moves leading to EPS upgrades. We continue to view GQG’s valuation as attractive (~10.7x FY24 PE); with executing on the broader diversification strategy likely required for a further and sustained valuation re-rating. Add maintained.

Mojo slows

Motorcycle Holdings
3:27pm
December 21, 2023
MTO have guided to 1H24 underlying EBITDA (pre-AAS16) of A$14-16m, down ~17% on the pcp (A$18.1m); and 36% below 2H23 (A$23.3m). The lower-than-expected guidance has been attributed to slowing sales demand within its wholesale new vehicle segment (Mojo) and increasing competitive pressures impacting margins. While we remain positive on the MTO business and broader strategy, Mojo’s diversified earnings base in mitigating a softer consumer backdrop had been a key element to our investment case. Given the guidance commentary and sharp deterioration in recent trade, the near-term outlook for the division is less certain. We lower our recommendation to a Hold, as we look for improved confidence and greater stability in the near-term earnings outlook of the combined business.

Funding the pipeline

Syntara
3:27pm
December 20, 2023
SNT is undertaking a A$10m equity raising via a two-tranche placement as well seeking to raise an additional A$2.2m via an SPP. The funds will be used towards the completion of three Phase 2 clinical trials in myelofibrosis, scarring and Parkinson’s disease. Following a review of our research universe, we revise our coverage approach for Syntara (SNT.AU). While we will continue to monitor and provide updates, we will cease providing a rating, valuation and forecasts. Thus, our forecasts, target price and recommendation should no longer be relied upon for investment decisions.

A tough environment blunting overall progress

PEXA Group
3:27pm
December 20, 2023
PXA has finalised its acquisition of Smoove and given a financial update. The trading update was soft overall with numerous headwinds across PXA’s operations. The financials for Smoove had been disclosed previously, and while this business provides a new avenue for growth, it is currently loss making. We lower our PXA FY25F/FY26F EPS by ~13%-17% factoring in revised FY24 guidance commentary and the inclusion of Smoove into our numbers. We lower our PXA price target to A$11.65 (from A$13.36) and move to a HOLD rating.

News & Insights

Treasury Secretary Scott Bessent’s adept negotiation of a US-China tariff deal and his method for assessing tariffs’ modest impact on inflation, using a 20.5% effective rate, position him as a formidable successor to Henry Morganthau’s legacy.

In the 1930s, the US Treasury Secretary Henry Morganthau was widely regarded as the finest Treasury Secretary since Alexander Hamilton. However, if the current Treasury Secretary Scott Bessent, continues to deliver results as he is doing now, he will provide formidable competition to Morganthau’s legacy.

The quality of Bessent’s work is exceptional, demonstrated by his ability to secure an agreement with China in just a few days in complex circumstances.

The concept of the "effective tariff rate" is a term that has gained traction recently. Although nominal tariff rates on individual goods in individual countries might be as high as 100% or 125%; the effective tariff rate, which reflects the actual tariffs the US imposes on imports from all countries, is thought to be only 20.5%. This figure comes from an online spreadsheet published by Fitch Ratings, since 24 April.

Finch Ratings Calculator Screenshot

This effective tariff rate of 20.5% can be used in assessing the impact of import tariffs on US inflation. To evaluate this, I used a method proposed by Scott Bessent during his Senate confirmation hearing. Bessent began by noting that imports account for only 16% of US goods and services that are consumed in the US Economy. In this case, a 10% revenue tariff would increase domestic prices by just 1.6%. With a core inflation rate of 2.8% in the US, this results in a headline inflation rate of 4.4%. Thus, the overall impact of such tariffs on the US economy is relatively modest.

A couple of weeks ago, Austan Goolsbee, the President of the Chicago Fed, noted that tariffs typically increase inflation, which might prompt the Fed to lift rates, but they also reduce economic output, which might prompt the Fed to rate cuts. Consequently, Goolsbee suggested that the Federal Reserve might opt to do nothing. This prediction was successful when the Open Market Committee of the Fed, with Goolsbee as a member, left the Fed Funds rate unchanged last week.

A 90-day agreement between the US and China, masterfully negotiated by Scott Bessent, has dramatically reduced tariffs between China and the US. China now only imposes a 10% import tariff on the US, while the US applies a 30% tariff on Chinese goods—10% as a revenue tariff and 20% to pressure China to curb the supply of fentanyl ingredients to third parties in Mexico or Canada. It is this fentanyl which fuels the US drug crisis. This is a priority for the Trump administration.

How Import Tariffs Affect US Inflation.

We can calculate how much inflation a tariff adds to the US economy in the same way as Scott Bessent by multiplying the effective tariff rate by the proportion that imports are of US GDP. Based on a 20.5% US effective tariff rate, I calculated that it adds 3.28% to the US headline Consumer Price Index (CPI). This results in a US headline inflation rate of 6.1% for the year ahead. In Australia, we can draw parallels to the 10% GST introduced 24 years ago, where price effects were transient and vanished after a year, avoiding sustained high inflation.

Before these negotiations, the US was levying a nominal tariff on China of 145%. Some items were not taxed, so meant that the effective tariff on China was 103%. Levying this tariff meant that the US faced a price effect of 3.28%, contributing to a 6.1% headline inflation rate.

If the nominal tariff rate dropped to 80%, the best-case scenario I considered previously, the price effect would fall to 2.4%, with a headline US inflation rate of 5.2%. With the US now charging China a 30% tariff, this adds only 2% to headline inflation, yielding a manageable 4.8% US inflation rate.

As Goolsbee indicated, the Fed might consider raising interest rates to counter inflation or cutting them to address reduced output, but ultimately, it is likely to maintain current rates, as it did last week. I anticipate the Fed will continue to hold interest rates steady but with an easing bias, potentially cutting rates in the second half of the year once the situation stabilises.

My current Fed Funds rate model suggests that, absent this year's tariff developments, the Fed would have cut rates by 50 basis points. This could be highly positive for the US economy.

Read more
In a lively presentation to the Economic Club of New York, Federal Reserve Bank of Chicago President Austan Goolsbee highlighted tariffs as a minor stagflation risk but emphasized strong U.S. GDP growth of around 2.6%, suggesting a resilient economy and potential for a soft landing.

I’d like to discuss a presentation delivered by Austan Goolsbee, President of the Federal Reserve Bank of Chicago, to the Economic Club of New York on 10 April. Austan Goolsbee, gave a remarkably animated talk about tariffs and their impact on the U.S. economy.

Goolsbee is a current member of the Federal Reserve’s Open Market Committee, alongside representatives from Washington, D.C., and Fed bank Presidents from Chicago, Boston, St. Louis, and Kansas City.  

Having previously served as Chairman of the Council of Economic Advisers in the Obama White House, Goolsbee’s presentation style in New York was notably different from his more reserved demeanour I had previously seen when I had attended a talk of his in Chicago.

During his hour-long, fast-paced talk, Goolsbee addressed the economic implications of tariffs. He recounted an interview where he argued that raising interest rates was not the appropriate response to tariffs, a stance that led some to label him a “Dove.” He humorously dismissed the bird analogy, instead likening himself to a “Data Dog,” tasked with sniffing out the data to guide decision-making.

Goolsbee explained that tariffs typically drive inflation higher, which might ordinarily prompt rate hikes. However, they also tend to reduce economic growth, suggesting a need to cut rates. This creates a dilemma where rates might not need adjustment at all. He described tariffs as a “stagflation event” but emphasised that their impact is minor compared to the severe stagflation of the 1970s.

When asked if the U.S. was heading towards a recession, Goolsbee said that the "hard data" was surprisingly strong.

Let us now look at our model of US GDP based on the Chicago Fed National Activity Index. This Index   incorporates 85 variables across production, sales, employment, and personal consumption.  In the final quarter of last year, this index indicated the GDP growth was slightly below the long-term average, suggesting a US GDP growth rate of 1.9% to 2%.

However, data from the first quarter of this year showed stronger growth, just fractionally below the long-term trend.

Using Our Chicago Fed model, we find that US GDP growth had risen from about 2% growth to a growth rate of around 2.6%, indicating a robust U.S. economy far from recessionary conditions.

Model of US GDP

We think that   increased government revenue from Tariffs might temper domestic demand, potentially guiding growth down towards 1.9% or 2% by year’s end. Despite concerns about tariffs triggering a downturn, this highlights the economy’s resilience and suggests   a “soft landing,” which could allow interest rates to ease, weaken the U.S. dollar, and boost demand for equities.

We will provide monthly reviews of these indicators. We note that, for now, the outlook for the U.S. economy remains very positive.

Read more
This discussion simplifies the US business cycle, highlighting how tariffs are projected to lower growth to 1.8% in 2025, reduce the budget deficit, and foster an extended soft landing, boosting equities and commodities through 2027.


I want to discuss a simplified explanation of the US business cycle, prompted by the International Monetary Fund's forecast released yesterday, which, for the first time, assessed the impact of tariffs on the US economy. Unlike last year's 2.8% growth, the IMF predicts a drop to 1.8% in 2025. This is slightly below my forecast of 1.9 to 2%. They further anticipate growth will decline to 1.7% in 2026, lower than my previous estimate of 2%. Growth then returns to 2% by 2027.

This suggests that increased tariffs will soften demand, but the mechanism is intriguing. Tariffs are expected to reduce the US budget deficit from about 7% of GDP to around 5%, stabilizing government debt, though more spending cuts are needed.  This reduction in US deficit reduces US GDP growth. This leads to a slow down.

The revenue from tariffs is clearly beneficial for the US budget deficit, but the outlook for the US economy now points to an extended soft landing. This is the best environment for equities and commodities over a two-year view. With below-trend growth this year and even softer growth next year, interest rates are expected to fall, leading the fed funds rate to drift downward in response to slower growth trends. Additionally, the US dollar is likely to weaken as the Fed funds rate declines, following a traditional US trade cycle model: falling interest rates lead to a weaker currency, which in turn boosts commodity prices.

This is particularly significant because the US is a major exporter of agricultural commodities, has rebuilt its oil industry, and is exporting LNG gas. The rising value of these commodities stimulates the economy, boosting corporate profits and setting the stage for the next surge in growth in a couple of years.

This outlook includes weakening US interest rates and rising commodity prices, continuing through the end of next year. This will be combined with corporate tax cuts, likely to be passed in a major bill in July, reducing US corporate taxes from 21% to 15%.  This outlook is very positive for both commodities and equities. Our model of commodity prices shows an upward movement, driven by an increase in international liquidity within the international monetary system.

With US dollar debt as the largest component in International reserves , as US interest rates fall, the creation of US government debt accelerates, increasing demand for commodities.  The recent down cycle in commodities is now transitioning to an extended upcycle through 2026 and 2027, fueled by this increased liquidity due to weaker interest rates.

Furthermore, the rate of growth in international reserves is accelerating, having reached a long-term average of about 7% and soon expected to rise to around 9%. Remarkably, the tariffs are generating a weaker US dollar, which drives the upward movement in commodity prices. This improvement in commodity prices is expected to last for at least the next two years, and potentially up to four years.

Read more